To directly assess the effects of the biguanide, metformin, on hepatic
gluconeogenesis, it was added at high therapeutic levels (90 mu g/ml)
to the medium perfusing an isolated rat liver. Lactate (1 mg/min) was
infused simultaneously along with [C-14]lactate with or without [H-3]
lactate. [6-H-3]glucose was added at the beginning of the perfusion in
studies where [H-3]lactate was not infused. Glucose levels decreased
relative to control studies (metformin dose = 0) and lactate concentra
tions increased in this closed system. Quantitative analysis of the re
lationship between labeled glucose and lactate indicated that the flux
of carbon from lactate to glucose and CO2 was halved, whereas reflux
from glucose to lactate increased by similar to 80%. This was corrobor
ated by measurement of labeled lactate extraction as well as glucose,
CO2, and lactate production across the liver. Glycogen content of the
liver fell by 60% relative to control and was greater for the gluconeo
genic pathway. These data are consistent with an inhibitory action of
metformin on gluconeogenesis, which is due to a primary inhibition of
hepatic lactate uptake.